International Biotechnology Trust’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,669
Closed -$890K 62
2023
Q1
$890K Hold
9,669
0.25% 53
2022
Q4
$1.38M Hold
9,669
0.43% 43
2022
Q3
$2.19M Buy
+9,669
New +$2.45M 0.7% 41

Other funds holding ACET

International Biotechnology Trust's ACET Position: Q2 2023 in Review

International Biotechnology Trust sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 9,669 shares — an estimated $890K sold.

International Biotechnology Trust first reported a position in ACET in Q3 2022 and held it in 3 quarters. The position peaked at $2.19M in Q3 2022. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

  • International Biotechnology Trust reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
  • International Biotechnology Trust sold 9,669 Adicet Bio shares in Q2 2023, an estimated $890K.
  • International Biotechnology Trust first reported a position in Adicet Bio in Q3 2022 and held it in 3 quarters.
  • International Biotechnology Trust's Adicet Bio position peaked at $2.19M in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.